A new paper has been posted online reinstating the safety of CRISPR, following last month’s controversial study.
RNA interference (RNAi), which is known to be an important antiviral mechanism in plants and invertebrates, also plays an antiviral role in mammals
Nan Fang tells us that R&D needs innovation and speed to achieve a delicate balance, and hopes the future will bring long-read sequencing that is more robust and accurate
A Boston family are in a race against time to raise money for research to help save their son’s life, after he was diagnosed with an extremely rare genetic disease at just six months old.
Shared genetic test results would allow insurers to offer more personalised policies, potentially lowers costs and assess policyholder risk much better.
Blocking a specific intestinal microbial pathway can prevent obesity and insulin resistance, as well as cause fat tissue to become more metabolically active
“Big data” research runs the risk of being undermined by the poor design of the digital identifiers that tag data.
Illumina has announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer.
Scientists have taken an important step toward safer gene-editing cures for life-threatening disorders, by developing a technique that can spot editing mistakes made by CRISPR to an individual’s genome.